National Research (NASDAQ:NRC – Get Free Report) was upgraded by equities researchers at Zacks Research to a “hold” rating in a report released on Monday, Zacks reports.
A number of other brokerages also recently weighed in on NRC. Citizens Jmp raised their target price on shares of National Research from $23.00 to $26.00 and gave the company a “market outperform” rating in a research note on Wednesday, July 29th. Weiss Ratings upgraded shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, August 21st. Finally, Wall Street Zen downgraded shares of National Research from a “buy” rating to a “hold” rating in a report on Saturday, August 15th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $26.00.
Get Our Latest Research Report on NRC
National Research Stock Down 3.4%
National Research (NASDAQ:NRC – Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.46. The firm had revenue of $35.39 million during the quarter, compared to analyst estimates of $34.90 million. National Research had a net margin of 4.18% and a return on equity of 164.26%. On average, equities research analysts anticipate that National Research will post 0.98 EPS for the current year.
Hedge Funds Weigh In On National Research
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its holdings in shares of National Research by 4.0% during the 1st quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after buying an additional 9,730 shares in the last quarter. Heartland Advisors Inc. increased its stake in shares of National Research by 374.3% in the 1st quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock worth $4,027,000 after acquiring an additional 187,147 shares in the last quarter. Bank of America Corp DE increased its stake in shares of National Research by 3.0% in the 1st quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock worth $1,910,000 after acquiring an additional 3,323 shares in the last quarter. Fifth Third Bancorp purchased a new position in National Research during the 1st quarter valued at about $1,531,000. Finally, Quantinno Capital Management LP lifted its position in National Research by 61.3% during the 1st quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock valued at $1,058,000 after acquiring an additional 23,682 shares during the period. Hedge funds and other institutional investors own 47.26% of the company’s stock.
About National Research
National Research Corporation, formerly traded on the Nasdaq under the symbol NRC and known as NRC Health, provides market research, analytics and performance-improvement services to healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers understand the experiences and expectations of patients, employees, physicians and communities.
The company’s offerings have included patient-experience measurement, employee and physician engagement surveys, reputation and brand research, community health assessments, data analytics and advisory services.
Read More
- Five stocks we like better than National Research
- The AI Boom’s Next Big Winners May Wear Hard Hats
- Rivian Escapes the EV Graveyard—But Can It Stay Alive?
- Allient’s Data Center and Defense Momentum Is Raising the Stakes
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
